Back to search

Boston University

The emergence of bispecific antibodies as novel cancer therapeutics

Abstract

dc:description.abstract

Bispecific antibodies have recently taken the immune-oncology field by storm through its multi-targeting capabilities and unique mechanisms of action. In the past few decades, this therapeutic format has seen an exponential rise, and with every year, new variations of the basic bispecific concept emerge to precipitate new effects. These effects include cell-to-cell binding, enhanced agonism or antagonism, and target internalization. One of the most promising applications for bispecific antibodies is as a bispecific T-cell engager, which can induce inflammatory responses in previously immune-excluded tumors. This paper aims to provide a high-level overview of the functionality, formats, and clinical results of bispecific antibodies and place them in the context of current treatments for cancer.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Li, Robert
Advisors dc:contributor.advisor
  • Trinkaus-Randall, Vickery E.
  • Qin, Yan

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/45586

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Li, Robert. The emergence of bispecific antibodies as novel cancer therapeutics. masters thesis, Boston University, 2022. https://hdl.handle.net/2144/45586